Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.



<ul>
<li>Baird raised the price target for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from $460 to $490 while maintaining a Neutral rating. CrowdStrike Holdings shares closed at $782.17 on Monday. See how other analysts view this stock.</li>



<li>HC Wainwright &amp; Co. lowered the price target for Fulcrum Therapeutics Inc. (NASDAQ:FULC) from $25 to $3 and downgraded the stock from Buy to Neutral. Fulcrum Therapeutics shares closed at $6.42 on Monday. See how other analysts view this stock.</li>



<li>Goldman Sachs raised the price target for HP Inc. (NYSE:HPQ) from $16 to $19 while maintaining a Sell rating. HP shares closed at $29.34 on Monday. See how other analysts view this stock.</li>



<li>HC Wainwright &amp; Co. cut the price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) from $1,250 to $1,200 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>



<li>Ascendiant Capital raised its price target for Genasys Inc. (NASDAQ:GNSS) from $5.50 to $6 and maintained a Buy rating. Genasys shares closed at $2.11 on Monday. See how other analysts view this stock.</li>



<li>Goldman Sachs lowered the price target for Intuit Inc. (NASDAQ:INTU) from $519 to $276 and downgraded the stock from Neutral to Sell. Intuit shares closed at $353.76 on Monday. See how other analysts view this stock.</li>



<li>Evercore ISI Group raised the price target for Guardant Health Inc. (NASDAQ:GH) from $95 to $160 and upgraded the stock from In-Line to Outperform. Guardant Health shares closed at $129.14 on Monday. See how other analysts view this stock.</li>



<li>Needham increased the price target for Credo Technology Group Holding Ltd. (NASDAQ:CRDO) from $220 to $275 while maintaining a Buy rating. Credo Technology Group Holding shares closed at $226.10 on Monday. See how other analysts view this stock.</li>



<li>BTIG lowered its price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) from $843 to $810 and maintained a Buy rating. Praxis Precision Medicines shares closed at $335.16 on Monday. See how other analysts view this stock.</li>



<li>BofA Securities cut the price target for Nu Holdings Ltd. (NYSE:NU) from $16 to $10 and downgraded the stock from Neutral to Underperform. Nu Holdings shares closed at $12.99 on Monday. See how other analysts view this stock.</li>
</ul>

INTU

CRDO

PRAX

FULC

CRWD

Wall Street analysts updated ratings and price targets for several stocks. Baird raised CrowdStrike's target to $490; Goldman Sachs raised HP's to $19 but lowered Intuit's to $276 with a downgrade. HC Wainwright downgraded Fulcrum Therapeutics to Neutral with a $3 target. Evercore ISI upgraded Guardant Health to Outperform, raising its target to $160. Needham increased Credo Technology's target to $275. BTIG slightly cut Praxis Precision Medicines' target, while BofA downgraded Nu Holdings to Underperform with a $10 target.

CrowdStrike To Gain 7%? Here Are 10 Top Analyst Forecasts For Tuesday